Codner Iris Beck 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Feb 19, 2019

Insider Transaction Report

Form 4
Period: 2019-02-14
Codner Iris Beck
EVP Global Brand&Communication
Transactions
  • Exercise/Conversion

    Restricted Share Units

    2019-02-143,2126,425 total
    Ordinary Shares (3,212 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2019-02-14+3,21217,996.036 total
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on February 14, 2017, with 3,212 vesting on each of February 14, 2019 and February 14, 2020 and 3,213 vesting on February 14, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION